Geode Capital Management, LLC Relmada Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 304,502 shares of RLMD stock, worth $118,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304,502
Previous 260,498 16.89%
Holding current value
$118,755
Previous $781,000 26.25%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$2.3 - $4.36 $101,209 - $191,857
44,004 Added 16.89%
304,502 $986,000
Q2 2024

Aug 09, 2024
BUY
$2.93 - $4.94 $12,924 - $21,790
4,411 Added 1.72%
260,498 $781,000
Q1 2024

May 13, 2024
BUY
$3.1 - $6.8 $39,289 - $86,183
12,674 Added 5.21%
256,087 $1.19 Million
Q4 2023

Feb 13, 2024
BUY
$2.45 - $4.22 $8,597 - $14,807
3,509 Added 1.46%
243,413 $1.01 Million
Q3 2023

Nov 13, 2023
BUY
$2.48 - $3.79 $13,744 - $21,004
5,542 Added 2.36%
239,904 $719,000
Q2 2023

Aug 11, 2023
SELL
$2.22 - $3.54 $594,917 - $948,652
-267,981 Reduced 53.35%
234,362 $576,000
Q1 2023

May 15, 2023
BUY
$2.24 - $4.76 $36,046 - $76,597
16,092 Added 3.31%
502,343 $1.14 Million
Q4 2022

Feb 13, 2023
SELL
$2.17 - $35.84 $9,897 - $163,466
-4,561 Reduced 0.93%
486,251 $1.7 Million
Q3 2022

Nov 14, 2022
SELL
$18.3 - $37.02 $119,224 - $241,185
-6,515 Reduced 1.31%
490,812 $18.2 Million
Q2 2022

Aug 12, 2022
BUY
$16.5 - $30.34 $699,979 - $1.29 Million
42,423 Added 9.33%
497,327 $9.44 Million
Q1 2022

May 13, 2022
BUY
$16.72 - $26.99 $1.86 Million - $2.99 Million
110,947 Added 32.26%
454,904 $12.3 Million
Q4 2021

Feb 11, 2022
BUY
$16.93 - $26.82 $1.53 Million - $2.42 Million
90,254 Added 35.57%
343,957 $7.75 Million
Q3 2021

Nov 12, 2021
BUY
$21.86 - $34.77 $204,850 - $325,829
9,371 Added 3.84%
253,703 $6.65 Million
Q2 2021

Aug 13, 2021
BUY
$29.55 - $39.15 $149,523 - $198,099
5,060 Added 2.11%
244,332 $7.82 Million
Q1 2021

May 12, 2021
BUY
$31.52 - $39.28 $1.06 Million - $1.32 Million
33,585 Added 16.33%
239,272 $8.42 Million
Q4 2020

Feb 12, 2021
BUY
$29.88 - $39.8 $162,457 - $216,392
5,437 Added 2.72%
205,687 $6.6 Million
Q3 2020

Nov 13, 2020
BUY
$34.42 - $43.78 $69,080 - $87,866
2,007 Added 1.01%
200,250 $7.53 Million
Q2 2020

Aug 13, 2020
BUY
$31.59 - $49.98 $2.86 Million - $4.53 Million
90,554 Added 84.09%
198,243 $8.87 Million
Q1 2020

May 14, 2020
BUY
$23.78 - $50.12 $251,616 - $530,319
10,581 Added 10.9%
107,689 $3.67 Million
Q4 2019

Feb 13, 2020
BUY
$10.1 - $47.18 $980,790 - $4.58 Million
97,108 New
97,108 $3.79 Million

Others Institutions Holding RLMD

# of Institutions
78
Shares Held
11.5M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $11.2M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email